Back to Results
First PageMeta Content
Amphetamines / Nootropics / Attention-deficit hyperactivity disorder / Childhood psychiatric disorders / Euphoriants / Lisdexamfetamine / Methylphenidate / Medical diagnosis / Concomitant drug / Medicine / Psychiatry / Pharmacology


Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology
Add to Reading List

Open Document

File Size: 64,17 KB

Share Result on Facebook

City

Reference / /

Company

D. Drug Utilization Data / NEC / Encuity Research LLC. / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

mentioned products / mentioned product / /

MedicalTreatment

drug therapy / /

OperatingSystem

OSE / /

Organization

FDA / U.S. Office / Pediatric Advisory Committee / Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation / office of Surveillance / office of Pediatric Therapeutics / Research office of Surveillance and Epidemiology Addendum Date / /

Person

Laura Governale / Grace Chai / LAURA A GOVERNALE / Kusum Mistry / /

Position

physician / contractor / Team Leader / Analysis Team Leader Division of Epidemiology / Deputy Director for Drug Utilization Division of Epidemiology / Deputy Director / Analyst Division of Epidemiology / /

Product

Seroquel / guanfacine hydrochloride / fluoxetine / Concerta / Adderall XR / Risperdal / Adderall / Vyvanse / Focalin XR / Zyprexa / IntunivĀ® (guanfacine hydrochloride) / /

SocialTag